Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - TOTAL DEBT REPAID
Total Debt Repaid HALO - Halozyme Therapeutics, Inc.
-13.5 M
LAST VALUE
-1.61%
2 YEAR CAGR
29.52%
5 YEAR CAGR
-5.29%
10 YEAR CAGR